SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

The Journal of Allergy and Clinical Immunology: In Practice（2022）

引用 10|浏览18

暂无评分

摘要

Our study confirms that despite the initial concerns, SARS-CoV-2 infection is not more common in asthmatics treated with biologics compared with the general population, whereas the use of biologic treatments for severe asthma during the COVID-19 pandemic does not seem to be related to adverse outcomes from severe COVID-19.

查看译文

关键词

Severe asthma,COVID-19,Biologics,Mepolizumab,Omalizumab,Benralizumab,Exacerbation,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要